Related Experiment Video

Updated: Jan 12, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.3K

Separase Inhibitor Sepin-1 Inhibits Foxm1 Expression and Breast Cancer Cell Growth

Nenggang Zhang1, Debananda Pati1

  • 1Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas, USA.

Journal of Cancer Science & Therapy
|May 22, 2018
PubMed

Insights

Sepin-1 inhibits breast cancer cell growth and migration by downregulating key cell cycle proteins. This mechanism, distinct from apoptosis, involves the Raf-Mek-Erk pathway and the transcription factor FoxM1.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Sepin-1, a separase inhibitor, shows anti-cancer properties, but its precise mechanism in breast cancer is unclear.
  • Understanding Sepin-1's effects on cell growth and migration is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying Sepin-1's inhibition of breast cancer cell growth, migration, and wound healing.
  • To investigate the impact of Sepin-1 on apoptosis, cell cycle regulators, and signaling pathways.

Main Methods:

  • In vitro studies on breast cancer cells treated with Sepin-1.
  • Analysis of apoptosis markers (caspase 3/7 activation, Parp cleavage).
  • Assessment of gene and protein expression, including FoxM1, Plk1, Cdk1, Aurora A, Lamin B1, and Raf kinases.

Main Results:

  • Sepin-1 inhibited breast cancer cell growth, migration, and wound healing without inducing apoptosis.
  • Sepin-1 treatment led to decreased expression of Forkhead box protein M1 (FoxM1) and its cell cycle-related target genes (Plk1, Cdk1, Aurora A, Lamin B1).
  • Sepin-1 also downregulated the expression of Raf kinase family members (A-Raf, B-Raf, C-Raf), which are upstream regulators of FoxM1.

Conclusions:

  • Sepin-1 inhibits breast cancer cell proliferation and migration primarily through growth inhibition, not apoptosis.
  • The mechanism involves the downregulation of the Raf-Mek-Erk signaling pathway, leading to reduced FoxM1 expression and subsequent inhibition of cell cycle progression.
  • These findings highlight Sepin-1 as a potential therapeutic agent for breast cancer by targeting key regulatory pathways.
Keywords:
Breast cancerCell proliferationFoxM1RafSeparaseSepin-1

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.0K
Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

12.6K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K